Medical devices are designed for decades-long commercial lives, but the components, software, and regulations they depend on are not. Without structured sustenance engineering, companies accumulate compounding engineering and regulatory debt that quietly erodes enterprise value, long after regulatory approval.
This whitepaper by Syrma Johari MedTech examines how proactive sustenance engineering protects product value, controls regulatory exposure, and extends commercial life without forcing costly redesigns, thereby ensuring greater portfolio stability.
The whitepaper presents a comprehensive framework for sustenance engineering across the full medical device lifecycle, grounded in five pillars: Obsolescence Intelligence, Controlled Re-Engineering, Documentation Continuity, Manufacturing Resilience, and Post-Market Feedback Loops. It outlines practical strategies, including:
Industry Leaders
Organizations Managing Mature or Legacy Products
With 54% of manufacturers having opted out of MDR transitions due to the burden of documentation remediation, the cost of unmanaged sustainment has never been clearer. Structured sustenance engineering is now a strategic imperative for all medical device companies.
Syrma Johari MedTech delivers sustenance engineering as a lifecycle responsibility, integrating engineering, regulatory, and manufacturing expertise through a cross-functional operating model. From diagnostic pilots to long-term portfolio stewardship, our teams help MedTech companies reduce risk, protect margins, and extend product value well beyond launch.
Schedule a consultation with our sustenance engineering experts today.
AI-Powered Assistant
